Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”

 

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

  • A detailed review of the overall landscape of fragment-based drug discovery library and service providers. 
  • Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).
  • An analysis of the partnerships that have been established in the recent past.
  • A detailed analysis on acquisition targets.
  • An insightful competitiveness analysis of fragment-based drug discovery library and service providers.
  • An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Type of Technique
  • X-ray Crystallography
  • Nuclear Magnetic Resonance
  • Surface Plasmon Resonance
  • Other Screening Techniques
  • Type of Service
  • Library Screening
  • Fragment Screening
  • Fragment Optimization
  • End User
  • Industry Players
  • Non-Industry Players
  • Key Geographical Region 
  • North America (US and Canada)
  • Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
  • Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

 

Key companies covered in the report:

  • 2bind
  • Charles River Laboratories
  • ChemAxon
  • ComInnex
  • Creative Biolabs
  • Creative Biostructure
  • CRELUX
  • Domainex
  • Evotec
  • Red Glead Discovery

Press Release: Variation 1 (Format 2)

 

  • SARomics Biostructures
  • Shanghai ChemPartner
  • Sygnature Discovery
  • Vernalis Research

 

For more information, please click on the following link: 

https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

 

 

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]